Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis.
about
Role of exosomes/microvesicles in the nervous system and use in emerging therapiesClinical significance of procoagulant microparticlesIncreased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritisRole of protease-activated and ADP receptor subtypes in thrombin generation on human platelets[Thrombocytopathy and blood complications in uremia].Antiphospholipid antibodies: paradigm in transition.Function and clinical significance of platelet-derived microparticles.A genome-wide linkage scan in German shepherd dogs localizes canine platelet procoagulant deficiency (Scott syndrome) to canine chromosome 27.Microparticles in stored red blood cells as potential mediators of transfusion complicationsMicrofluidic isolation and transcriptome analysis of serum microvesicles.Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome.FEIBA: mode of action.Autophagy is induced upon platelet activation and is essential for hemostasis and thrombosis.Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer.An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling.Physiology of membrane lipid asymmetry.Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes.Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen.Critical micelle concentrations and stirring are rate limiting in the loss of lipid mass during membrane degradation by phospholipase A2.Association between vascular access failure and microparticles in hemodialysis patients.Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia.Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia.Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin.Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation.A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa.Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granulesImpaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndrome.In vitro function and phagocytosis of galactosylated platelet concentrates after long-term refrigeration.Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
P2860
Q21129255-ED726EA5-7A1B-4EA6-A24A-8A71CE4804F8Q26830846-397CB6F8-7D79-40BF-929F-5F60A1CDDB79Q28191467-3C344221-2A6E-4F70-AA02-38CCD4817601Q28257658-BD2F7D8B-DAD5-4DA2-A663-788A8899C1A4Q33371562-688B42AB-E263-49CA-823D-D0CB9506608AQ33382848-BE5BC767-AE58-4403-9AC0-96AB3B417391Q34496416-BA4307EA-33A7-404A-BF88-E4A5D028A4DBQ34724482-62FF11FE-5B33-48F0-861E-D52513E08E27Q34983553-4BD9F05C-7C09-4640-BD25-42A963445BD8Q35106801-BC83E123-FE1C-4559-B85E-3DDCDBBA1176Q35824436-9C46226A-1FF8-4502-A0FF-06EDEF76581FQ35895858-D3FF40F5-9D33-482E-BC1D-9620705E6684Q36027454-2988FE0C-D039-4922-A2E6-24AC0A540781Q39781488-6887BB43-D7BF-4C1D-95DF-ED239A611637Q40449101-258B2012-5442-4F7D-81A5-80133C5CD505Q40491758-78E535FD-47B1-4B40-B69C-38B6FF88FCA8Q40558482-8E5AC708-CC87-4C36-8AD9-EBB40D960A33Q40613596-E9AE4556-3F66-4004-9FAE-B7BB7AD24B48Q41975625-14A0EE73-7FB9-4B4B-BDA0-02FAD668B062Q41980886-453F09CF-6589-4BA5-A593-9311768FCF29Q42129359-4541C8CD-F415-46ED-B9E5-842A89F8DA32Q43567892-63EE7C14-59E0-4B03-A075-125A0280AEE5Q43591838-080B2936-693E-4CD1-9D73-B452CF89E3C1Q43980523-ABD287E5-A963-4CD5-A337-70A22A6810E3Q45013438-C43864D3-8705-4CC7-8574-B9C244B8B5A7Q47254315-8034E820-6918-413B-90DE-C97974C6E33BQ47327362-50D086F6-7660-45DB-9606-047E3E9431AAQ47367663-3B81383A-3EDC-4DD2-AF34-2C3E95F399DCQ47976874-F0A38158-48CE-41B7-B78A-536E01949522Q52162420-F2491EDC-28E5-416F-815A-9412C6960ECCQ52530598-823630FD-BA1D-46C5-961B-52D32D77D8C2Q53569453-5B7BF521-498C-4C24-ACF8-45CA9FD06CF8Q53598292-AE7648D6-65BB-4EAE-97B0-9FA6509F5FD3
P2860
Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Platelet procoagulant activity ...... in hemostasis and thrombosis.
@ast
Platelet procoagulant activity ...... in hemostasis and thrombosis.
@en
type
label
Platelet procoagulant activity ...... in hemostasis and thrombosis.
@ast
Platelet procoagulant activity ...... in hemostasis and thrombosis.
@en
prefLabel
Platelet procoagulant activity ...... in hemostasis and thrombosis.
@ast
Platelet procoagulant activity ...... in hemostasis and thrombosis.
@en
P2093
P1476
Platelet procoagulant activity ...... in hemostasis and thrombosis.
@en
P2093
E M Bevers
P Comfurius
P356
10.1016/0925-4439(92)90019-J
P407
P577
1992-10-01T00:00:00Z